Pembrolizumab Plus Olaparib in Patients With Recurrent Cervical Cancer
Clinical trial NCT04641728 · UNKNOWN
Trial details
- NCT number
- NCT04641728
- Sponsor
- Saitama Medical University International Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2022-12-31
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.